Similar Search Results

Drug Policy 1986

eSocialSciences - 2005

Drug Policy of 1986

Persistent link: https://www.econbiz.de/10009323735

Srinivasan, S - eSocialSciences - 2005

This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines â€“ including medicines for HIV AIDS …

Persistent link: https://www.econbiz.de/10005699276

Draft National Pharmaceuticals Pricing Policy, 2011 (NPPP 2011)

eSocialSciences; Pharmaceuticals Department of - 2011

TheÂ DrugÂ Policy,Â 1994Â neededÂ toÂ beÂ revisedÂ toÂ meetÂ theÂ challengesÂ broughtÂ aboutÂ byÂ theÂ competitiveÂ internationalÂ pharmaceuticalÂ industryÂ inÂ aÂ globalisedÂ economicÂ environment,Â as...

Persistent link: https://www.econbiz.de/10009358535

Modifications in Drug Policy 1986

eSocialSciences - 2005

Modifications to Drug Policy 1986

Persistent link: https://www.econbiz.de/10009250151

Pharmaceutical Policy, 2002

eSocialSciences - 2005

Pharmaceutical Policy of 2002 covering issues of pricing, ,marketing, size of market, quality, production, investment, regulatory authority, monitoring, ethical issues

Persistent link: https://www.econbiz.de/10009250530

The Drugs And Cosmetics (Amendment) Bill, 2005

eSocialSciences - 2005

THE DRUGS AND COSMETICS (AMENDMENT) BILL, 2005 A Bill further to amend the Drugs and Cosmetics Act, 1940. Under examination with the Committee on Health and Family Welfare On adulterated and spurious drugs

Persistent link: https://www.econbiz.de/10005528115

Task Force to Explore Options other than Price Control for Achieving the Objective of Making Available Life-saving Drugs at Reasonable Prices

Pricing, Task Force on Pharmaceutical - eSocialSciences - 2005

The Task Force recommends that price regulation should be on the basis of â€˜Essentialityâ€™ of the drug and it should be applied only to formulations and not to upstream products, such as bulk drugs. No effort should be made to impose a uniform price, and only a ceiling price should be...

Persistent link: https://www.econbiz.de/10005528148

Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India

Chaudhuri, Shubham; Goldberg, Pinelopi K.; Jia, Panle - eSocialSciences - 2006

product patents for pharmaceuticals, this paper provides a rigorously-derived estimate of the possible impact of …-bacterials (i.e., antibiotics) in the Indian pharmaceuticals market. These estimates are then used to carry out counterfactual …

Persistent link: https://www.econbiz.de/10005528220

Guidelines for the Examination of Pharmaceutical Patents: Developing a Public Health Perspective

Correa, Carlos - eSocialSciences - 2007

examination for pharmaceuticals inventions, particularly in developing countries. It proposes a set of general guidelines for the …

Persistent link: https://www.econbiz.de/10005528232

Intellectual Property and Access to Medicines

Onori, Andrea - eSocialSciences - 2007

This report analyzes the ITRIPS agreement. It discuses the problems and stakes, and consequences of this agreement. The report also provides case studies related to the topic and finally gives a suggestive conclusion.

Persistent link: https://www.econbiz.de/10005528311